After Effects of Recession in the Healthcare Industry - What is in Store for the Investors?

NEW YORK, July 19, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

After Effects of Recession in the Healthcare Industry- What is in store for the Investors?

http://www.reportlinker.com/p0574362/After-Effects-of-Recession-in-the-Healthcare-Industry--What-is-in-store-for-the-Investors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Healthcar

This study helps the investor by providing a quantitative overview of the historical trends in macro economic scenario that helped shape the healthcare industry. It also provides a snapshot of mergers and acquisitions in the healthcare industry classified by time, segments, deal volume, average deal size, diversification by geographies, types of integration and deal multiples.

Table of Contents

RESEARCH OBJECTIVE AND SCOPE 9

INTRODUCTION 10-14

GEOGRAPHY ANALYSIS 15

Deal Volume Across Target and Acquiring Geographies 16-17

Classification by Deal Volume across Deal Multiples 18

SEGMENT ANALYSIS 19

Comparison of Number of Deals across Segments and Target Geographies 20-21

Comparison of Number of Deals across Segments 22

Comparison of Number of Deals across Segments (North America) 23

Comparison by Average Deal Size 24

Comparison by Average Deal Size and Target Geographies 25

Deal Volume Classification by Segments and Deal Multiples 26-27

Key Takeaways based on Deal Count and Average Deal Size across Various Segments 28

Classification by Deal Value and Proportionate Deal Ranges 29

Classification by Type of Acquisition and Deal Count 30

Classification by Type of Acquisition and Deal Value 31

Classification by Geographies and Proportionate Deal Ranges 32

Classification by Number of Deals and Type of Ownership 33

ANALYSIS BY TYPE OF ACQUISITION 34

Analysis by Number of Deals and Type of Ownership 35

Analysis by Deal Value and Type of Ownership 36

Analysis across Segments, Average Deal Size and Number of Deals 37

Classification by Deal Multiple and Deal Volume 38

ANALYSIS BY TIME 39

Classification by Deal Volume and Deal Ranges across Types of Acquisition 40

Classification by Deal Multiples and Number of Deals 41

ANALYSIS BY DEAL RANGES & TYPE OF OWNERSHIP 42

Classification by Deal Multiples and Average Deal Size 43

Comparison Across Number of Deals and Years 44

Classification by Deal Value to Sales, Average Deal Size 45

CONCLUSION AND STRATEGIC RECOMMENDATIONS 46

Key Factors Influencing the Mergers and Acquisition Market 47-49

ABOUT FROST & SULLIVAN 50-54

List of Figures

Healthcare Industry: Comparison of Deals across Target and Acquiring Geographies (Global), 2006-2007 16

Healthcare Industry: Comparison of Deals across Target and Acquiring Geographies (Global), 2008 16

Healthcare Industry: Comparison of Deals across Target and Acquiring Geographies (Global), 2009-March 2011 17

Healthcare Industry: Classification by Deal Value to Sales (Global), 2009 to March 2011 18

Healthcare Industry: Comparison of Deals across Target Segments and Geographies (Global), 2006-2007 20

Healthcare Industry: Comparison of Deals across Target Segments and Geographies (Global), 2008 20

Healthcare Industry: Comparison of Deals across Target Segments and Geographies (Global), 2009-March 2011 21

Healthcare Industry: Comparison of Average Deal Size across Target Segments and Geographies (Global), 2009-March 2011 21

Healthcare Industry: Overall Average Deal Size (Global), 2009-March 2011 24

Healthcare Industry: Overall Average Deal Size without the Biggest Deal (Global), 2009-March 2011 24

Healthcare Industry: Overall Average Deal Size across Target Geographies (Global), 2009-March 2011 25

Healthcare Industry: Overall Average Deal Size across Target Geographies without the Biggest Deal (Global), 2009-March 2011 25

Healthcare Industry: Classification by Deal Value to Sales across Segments (Global), 2009-March 2011 26

Healthcare Industry: Classification by Deal Value to Sales across Segments and Deal Multiples (Global), 2009-March 2011 27

Healthcare Industry: Classification Type of Acquisition, Segmental Analysis, and Average Deal Size and Deal Count (Global), 2009-March 2011 37

Healthcare Industry: Classification by Deal Value to Sales across Deal Ranges and Type of Acquisition (Global), 2009-March 2011 38

Healthcare Industry: Classification by Deal Value to Sales across Deal Ranges and Deal Multiples (Global), 2009-March 2011 43

Healthcare Industry: Classification by Deal Value to Sales, Average Deal Size and Type of Ownership (Global), 2009-March 2011 45

List of Charts

Healthcare Industry: Competitive Benchmarking across Healthcare and PESTLE Parameters (OECD Countries), 2009-2010 11

Healthcare Industry: Comparison of Number of Deals across Deal Ranges (Global), 2006-2010 12

Healthcare Industry: Comparison of Number of Deals (Global), 2006-2010 13

Healthcare Industry: Comparison of Number of Deals across Segments (Global), 2006-2010 14

Healthcare Industry: Comparison of Deal Volume Across Target and Acquiring Geographies, 2006-2007 16

Healthcare Industry: Comparison Across Regional versus International Deals (Global), 2009-March 2011 17

Healthcare Industry: Comparison of Deals across Years and Target Segments (Global), 2009-2010 22

Healthcare Industry: Comparison of Deals across Years and Target Segments (North America), 2009-2010 23

Healthcare Industry: Classification by Deal Value, and Segments and proportionate deal ranges (Global), 2009-March 2011 29

Healthcare Industry: Classification by Type of Acquisition, Segments and Deal Count (Global), 2009-March 2011 30

Healthcare Industry: Classification by Type of Acquisition, Segments and Deal Value (Global), 2009-March 2011 31

Healthcare Industry: Classification by Geographies, Segments and Proportionate Deal Ranges (Global), 2009-March 2011 32

Healthcare Industry: Classification by Segments, Number of Deals and Type of Ownership (Global), 2009-March 2011 33

Healthcare Industry: Classification by Segments, Deal Value and Type of Ownership (Global), 2009-March 2011 33

Healthcare Industry: Classification of Acquisition by Ownership by Deal Count (Global), 2009-March 2011 35

Healthcare Industry: Classification of Acquisition by Ownership by Deal Value (Global), 2009-March 2011 36

Healthcare Industry: Classification by Years and Type of Merger (Global), 2009-March 2011 40

Healthcare Industry: Classification by Deal Count and Deal Multiples (Global), 2009-March 2011 41

Healthcare Industry: Classification by deal Ranges and Deal Count (Global), 2009-March 2011 44

Healthcare Industry: Classification by Deal Value to Sales, Deal Count and Type of Ownership (Global), 2009-March 2011 45

To order this report:

Healthcare Industry: After Effects of Recession in the Healthcare Industry- What is in store for the Investors?

Healthcare Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Suggested Articles

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…